Harrow (HROW) Return on Capital Employed (2011 - 2026)
Harrow (HROW) recorded quarterly Return on Capital Employed of 6.18% in Q1 2026, down 42.26% quarter-over-quarter from 10.71% in Q4 2025, and up 380.0% on a YoY basis from 1.29% in Q1 2025.
Harrow (HROW) Return on Capital Employed (2011 - 2026) Analysis & Trends
Harrow's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 6.18% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 380.0% year-over-year to 6.18%; the TTM figure through Mar 2026 stood at 6.18% (up 380.0% YoY), while the FY2025 annual figure was 10.24%, up 684.0% from the prior year.
- Return on Capital Employed was 6.18% for Q1 2026 at Harrow, down from 10.71% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 13.62% in Q2 2025 to a low of 3.82% in Q3 2024.
- Historically, Return on Capital Employed has averaged 2.45% across 5 years, with a median of 1.49% in 2023.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed plunged 1737 bps in 2022, then soared 1706 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 1.75% in 2022, then slumped by 90 bps to 0.17% in 2023, then soared by 1733 bps to 3.16% in 2024, then soared by 239 bps to 10.71% in 2025, then plunged by 42 bps to 6.18% in 2026.
- The last three Return on Capital Employed figures came in at 6.18% (Q1 2026), 10.71% (Q4 2025), and 9.64% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.92% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.85% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -1.92% |
| 10 | Harrow | 1.23 Bn | 1.14 Bn | 27.05 Mn | 6.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.18% |
| Dec 31, 2025 | 10.71% |
| Sep 30, 2025 | 9.64% |
| Jun 30, 2025 | 13.62% |
| Mar 31, 2025 | 2.38% |
| Dec 31, 2024 | 3.16% |
| Sep 30, 2024 | -3.82% |
| Jun 30, 2024 | -3.45% |
| Mar 31, 2024 | -2.94% |
| Dec 31, 2023 | 0.17% |
| Sep 30, 2023 | 1.49% |
| Jun 30, 2023 | 0.85% |
| Mar 31, 2023 | 0.61% |
| Dec 31, 2022 | 1.75% |
| Sep 30, 2022 | 2.42% |
| Jun 30, 2022 | -1.98% |
| Mar 31, 2022 | 0.90% |
| Dec 31, 2021 | 1.78% |
| Sep 30, 2021 | 6.35% |
| Jun 30, 2021 | 15.39% |